Fig. 8.
Fig. 8. FITC-DX uptake by CD11b−/dullCD11c+ precursors (▧) and CD11b+hiCD11c+ DC precursors (▧) at day 6 and their derived CD11b−/dullCD11c+ mature DCs at days 12 to 14. Cells were first exposed to 0.1 mg/mL of FITC-DX at 0°C and 37°C, respectively, for 60 minutes. After washing twice, the cells were stained with rat–anti-mouse CD11b and biotinylated hamster–anti-mouse CD11c and then shown by PE-conjugated anti-rat Ig and CY-conjugated-streptavidin. A three-color immunofluorescence analysis was performed to show the capacity of FITC-DX uptake by these cells as indicated. *P < .01 significance compared with CD11b−/dullCD11c+ (▥) and CD11b+hiCD11c+ (□) DC precursor-derived mature DCs. Results are representative of three experiments.

FITC-DX uptake by CD11b−/dullCD11c+ precursors (▧) and CD11b+hiCD11c+ DC precursors (▧) at day 6 and their derived CD11b−/dullCD11c+ mature DCs at days 12 to 14. Cells were first exposed to 0.1 mg/mL of FITC-DX at 0°C and 37°C, respectively, for 60 minutes. After washing twice, the cells were stained with rat–anti-mouse CD11b and biotinylated hamster–anti-mouse CD11c and then shown by PE-conjugated anti-rat Ig and CY-conjugated-streptavidin. A three-color immunofluorescence analysis was performed to show the capacity of FITC-DX uptake by these cells as indicated. *P < .01 significance compared with CD11b−/dullCD11c+ (▥) and CD11b+hiCD11c+ (□) DC precursor-derived mature DCs. Results are representative of three experiments.

Close Modal

or Create an Account

Close Modal
Close Modal